Literature DB >> 2165399

Agonist-induced desensitization of cholinergically stimulated phosphoinositide breakdown is independent of endogenously activated protein kinase C in HT-29 human colon carcinoma cells.

R Kopp1, P Mayer, A Pfeiffer.   

Abstract

Activation of M3 muscarinic receptors in HT-29 cells by carbachol rapidly increases polyphosphoinositide breakdown. Pretreatment of these cells with carbachol (0.1 mM) for 5 h completely inhibits the subsequent ability of carbachol to increase [3H]inositol monophosphate ([3H]InsP) accumulation, paralleled by a total loss of muscarinic binding sites. In contrast, protein kinase C (PK-C)-mediated desensitization by incubation with phorbol esters [PMA (phorbol 12-myristate 13-acetate)], leading to a time- and dose-dependent inhibition of cholinergically stimulated InsP release (95% inhibition after 4 h with 0.1 microM-PMA), is accompanied by only a 40% decrease in muscarinic receptor binding, which suggests an additional mechanism of negative-feedback control. Neither carbachol nor PMA pretreatment had any effect on receptor affinity. Incubation with carbachol for 15 min caused a small increase of membrane-associated PK-C activity (15% increase, P less than 0.05) as compared with the potency of phorbol esters (PMA) (3-4-fold increase, P less than 0.01). Long-term incubation (4-24 h) with PMA resulted in a complete down-regulation of cytosolic and particulate PK-C activity. Stimulation of InsP release by NaF (20 mM) was not affected after a pretreatment with phorbol esters or carbachol, demonstrating an intact function of G-protein and phospholipase-C (PL-C) at the effector side. Determination of PL-C activity in a liposomal system with [3H]PtdInsP2 as substrate, showed no change in PL-C activity after carbachol (13 h) and short-term PMA (2.5 h) pretreatment, whereas long-term preincubation with phorbol esters (13 h) caused a small but significant decrease in PL-C activity (19%, P less than 0.05). Our results indicate that agonist-induced desensitization of phosphoinositide turnover occurs predominantly at the receptor level, with a rapid loss of muscarinic receptors. Exogenous activation of PK-C by phorbol esters seems to dissociate the interaction between receptor and G-protein/PL-C, without major effects on total cellular PL-C activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165399      PMCID: PMC1131533          DOI: 10.1042/bj2690073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Calcium-activated, phospholipid-dependent protein kinase (protein kinase C) from rat brain.

Authors:  U Kikkawa; R Minakuchi; Y Takai; Y Nishizuka
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Agonist and guanine nucleotide modulation of muscarinic cholinergic receptors in cultured heart cells.

Authors:  J B Galper; T W Smith
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

5.  Phosphoinositide interconversion in thrombin-stimulated human platelets.

Authors:  D B Wilson; E J Neufeld; P W Majerus
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

6.  Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type.

Authors:  A Pfeiffer; H Rochlitz; B Noelke; R Tacke; U Moser; E Mutschler; G Lambrecht
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

7.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

8.  Phorbol myristate acetate stimulates formation of phosphatidyl inositol 4-phosphate and phosphatidyl inositol 4,5-bisphosphate in human platelets.

Authors:  S P Halenda; M B Feinstein
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

9.  Mitogens increase phosphorylation of phosphoinositides in thymocytes.

Authors:  M V Taylor; J C Metcalfe; T R Hesketh; G A Smith; J P Moore
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

10.  The polyphosphoinositide phosphodiesterase of erythrocyte membranes.

Authors:  C P Downes; R H Michell
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

View more
  5 in total

1.  Signal transduction pathways mediating mucin secretion from intestinal goblet cells.

Authors:  T E Phillips; J Wilson
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

2.  Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma.

Authors:  G B Willars; R A Challiss; J A Stuart; S R Nahorski
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

3.  Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line.

Authors:  E B Haddad; J Rousell; J C Mak; P J Barnes
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

4.  Signal transduction pathway of the muscarinic receptors mediating gallbladder contraction.

Authors:  T von Schrenck; B Mackensen; U Mende; W Schmitz; J Sievers; S Mirau; A Raedler; H Greten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

5.  Characterization of phosphoinositide-specific phospholipase C in rat colonocyte membranes.

Authors:  M J Bolt; B M Bissonnette; R K Wali; S C Hartmann; T A Brasitus; M D Sitrin
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.